ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 680935 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 680935; 2) Community: the network communities that were significantly associated with the response to NSC 680935; 3) Molecule: the relationships between components within communities and NSC 680935; 4) MDR: the compounds that were significantly associated with the NSC 680935.

NSC Compound Enrichment Correlation
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0329129886465387 0.4706014
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0329129886465387 0.54085889
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0329129886465387 0.46614548
NSC 749600 Null 0.0329129886465387 0.46674756
NSC 750050 Null 0.0329129886465387 0.33091186
NSC 752346 Null 0.0329129886465387 0.17355985
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.0329129886465387 0.37403516
NSC 755442 Null 0.0329129886465387 0.14392401
NSC 758670 TANNIC ACID 0.0329129886465387 -0.19744055
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0329129886465387 0.25561812
Total:135  Current:105    [First] [Prev] [Next] [Last]